Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $116.37 million. The enterprise value is $94.46 million.
Market Cap | 116.37M |
Enterprise Value | 94.46M |
Important Dates
The next estimated earnings date is Thursday, February 6, 2025, after market close.
Earnings Date | Feb 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.39 million shares outstanding. The number of shares has increased by 0.16% in one year.
Current Share Class | 16.39M |
Shares Outstanding | 16.39M |
Shares Change (YoY) | +0.16% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 19.62% |
Owned by Institutions (%) | 24.08% |
Float | 12.83M |
Valuation Ratios
The trailing PE ratio is 12.48 and the forward PE ratio is 14.01.
PE Ratio | 12.48 |
Forward PE | 14.01 |
PS Ratio | 2.80 |
Forward PS | 2.61 |
PB Ratio | 2.15 |
P/TBV Ratio | 2.15 |
P/FCF Ratio | 55.65 |
P/OCF Ratio | 43.68 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.77, with an EV/FCF ratio of 45.18.
EV / Earnings | 10.15 |
EV / Sales | 2.29 |
EV / EBITDA | 7.77 |
EV / EBIT | 7.91 |
EV / FCF | 45.18 |
Financial Position
The company has a current ratio of 10.52, with a Debt / Equity ratio of 0.01.
Current Ratio | 10.52 |
Quick Ratio | 7.59 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.05 |
Debt / FCF | 0.31 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 18.86% and return on invested capital (ROIC) is 14.90%.
Return on Equity (ROE) | 18.86% |
Return on Assets (ROA) | 13.52% |
Return on Capital (ROIC) | 14.90% |
Revenue Per Employee | $1.18M |
Profits Per Employee | $266,029 |
Employee Count | 35 |
Asset Turnover | 0.75 |
Inventory Turnover | 1.05 |
Taxes
In the past 12 months, SRTS has paid $3.56 million in taxes.
Income Tax | 3.56M |
Effective Tax Rate | 27.66% |
Stock Price Statistics
The stock price has increased by +166.92% in the last 52 weeks. The beta is 1.18, so SRTS's price volatility has been higher than the market average.
Beta (5Y) | 1.18 |
52-Week Price Change | +166.92% |
50-Day Moving Average | 7.53 |
200-Day Moving Average | 5.81 |
Relative Strength Index (RSI) | 32.61 |
Average Volume (20 Days) | 190,343 |
Short Selling Information
The latest short interest is 486,058, so 2.97% of the outstanding shares have been sold short.
Short Interest | 486,058 |
Short Previous Month | 593,721 |
Short % of Shares Out | 2.97% |
Short % of Float | 3.79% |
Short Ratio (days to cover) | 6.14 |
Income Statement
In the last 12 months, SRTS had revenue of $41.31 million and earned $9.31 million in profits. Earnings per share was $0.57.
Revenue | 41.31M |
Gross Profit | 25.16M |
Operating Income | 11.94M |
Pretax Income | 6.45M |
Net Income | 9.31M |
EBITDA | 12.15M |
EBIT | 11.94M |
Earnings Per Share (EPS) | $0.57 |
Balance Sheet
The company has $22.56 million in cash and $651,000 in debt, giving a net cash position of $21.91 million or $1.34 per share.
Cash & Cash Equivalents | 22.56M |
Total Debt | 651,000 |
Net Cash | 21.91M |
Net Cash Per Share | $1.34 |
Equity (Book Value) | 54.13M |
Book Value Per Share | 3.30 |
Working Capital | 49.60M |
Cash Flow
In the last 12 months, operating cash flow was $2.66 million and capital expenditures -$573,000, giving a free cash flow of $2.09 million.
Operating Cash Flow | 2.66M |
Capital Expenditures | -573,000 |
Free Cash Flow | 2.09M |
FCF Per Share | $0.13 |
Margins
Gross margin is 60.90%, with operating and profit margins of 28.91% and 22.54%.
Gross Margin | 60.90% |
Operating Margin | 28.91% |
Pretax Margin | 31.16% |
Profit Margin | 22.54% |
EBITDA Margin | 29.42% |
EBIT Margin | 28.91% |
FCF Margin | 5.06% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.16% |
Shareholder Yield | -0.16% |
Earnings Yield | 8.00% |
FCF Yield | 1.80% |
Analyst Forecast
The average price target for SRTS is $12.50, which is 76.06% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.50 |
Price Target Difference | 76.06% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 32.50% |
EPS Growth Forecast (5Y) | 148.77% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 9.78 and a Piotroski F-Score of 6.
Altman Z-Score | 9.78 |
Piotroski F-Score | 6 |